Cargando…
The role of carbapenems in initial therapy for serious Gram-negative infections
The treatment of patients with serious Gram-negative infections must be both prompt and correct. Numerous studies have demonstrated that mortality risk is significantly increased when the initial antibiotic regimen does not adequately cover the infecting pathogen. Furthermore, changing to an appropr...
Autor principal: | Rahal, James J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2391262/ https://www.ncbi.nlm.nih.gov/pubmed/18495062 http://dx.doi.org/10.1186/cc6821 |
Ejemplares similares
-
Therapy of Infections due to Carbapenem-Resistant Gram-Negative Pathogens
por: Lee, Chang-Seop, et al.
Publicado: (2014) -
Serious gram-negative infections in the hospital /
Publicado: (1978) -
Temocillin use as a carbapenem-sparing option in a UK teaching hospital for treating serious Gram-negative bacterial infections
por: Enoch, D A, et al.
Publicado: (2022) -
Case series of cefiderocol for salvage therapy in carbapenem-resistant Gram-negative infections
por: Gavaghan, Victoria, et al.
Publicado: (2022) -
The role of new carbapenem combinations in the treatment of multidrug-resistant Gram-negative infections
por: Bouza, Emilio
Publicado: (2021)